LONCASTUXIMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Name

Type

Language

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD19 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL RB4V1.2 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RB4V1.2 .KAPPA.-CHAIN, DIMER

Preferred Name

English

LONCASTUXIMAB

Official Name

English

loncastuximab [INN]

Common Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS B-LYMPHOCYTE ANTIGEN CD-19)CHIMERIC MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-449) (MUS MUSCULUS VH (IGHV1-69*02 (86%) (IGHD)-IGHJ4*01)) (8.8.13) (1-120) -HOMO SAPIENS IGHG1*03 (CH1(K97>R(217)), CH3(K107>DEL(4

Systematic Name

English

LONCASTUXIMAB [USAN]

Common Name

English

Code System Code Type Description

INN

10585

Created by admin on Tue Apr 01 21:38:52 GMT 2025 , Edited by admin on Tue Apr 01 21:38:52 GMT 2025

PRIMARY

CAS

1875032-68-0

Created by admin on Tue Apr 01 21:38:52 GMT 2025 , Edited by admin on Tue Apr 01 21:38:52 GMT 2025

PRIMARY

SMS_ID

300000025306

Created by admin on Tue Apr 01 21:38:52 GMT 2025 , Edited by admin on Tue Apr 01 21:38:52 GMT 2025

PRIMARY

FDA UNII

NYM5HO7I39

Created by admin on Tue Apr 01 21:38:52 GMT 2025 , Edited by admin on Tue Apr 01 21:38:52 GMT 2025

PRIMARY

USAN

FG-28

Created by admin on Tue Apr 01 21:38:52 GMT 2025 , Edited by admin on Tue Apr 01 21:38:52 GMT 2025

PRIMARY

NCI_THESAURUS

C174770

Created by admin on Tue Apr 01 21:38:52 GMT 2025 , Edited by admin on Tue Apr 01 21:38:52 GMT 2025

PRIMARY

ACTIVE MOIETY


					NYM5HO7I39